Lion's Mane Benefits: 9 Proven Actions of Hericium 2026

Lion's mane, in Polish soplówka jeżowata, and in Latin Hericium erinaceus, has transitioned in the last decade from Asian cuisine to neurobiological laboratories. However, the evidence material in humans is significantly more modest than commercial descriptions suggest: a systematic review from 2025 gathered five randomized controlled trials and three pilot studies. This text goes through them one by one, showing exactly what was measured, correcting the mechanism that has been repeated for several years against the work it cites, and explaining why one of the popular arguments regarding Parkinson's disease should not be used at all today. You will also find an account of nine declared health benefits, divided according to what has been studied in humans, what is solely animal model research, and what has no basis other than repetition.

KEY INFORMATION
• The systematic review by Menon et al. (Frontiers in Nutrition, 2025) included five randomized trials and three pilot studies. The improvement in the MMSE scale averaged 1.17 points in the intervention group.
• The study by Mori et al. from 2009: 30 people aged 50 to 80 with mild cognitive impairment, 3 g of dried fruit body daily for 16 weeks, improvement in the HDS-R scale. Four weeks after discontinuation, the results significantly dropped.
• Contrary to common descriptions, hericenones C, D, and E did not stimulate NGF gene expression in the study by Mori et al. from 2008. The authors stated directly that the active compounds are not hericenones.
• Erinacine A penetrates the blood-brain barrier in rats through passive diffusion, with an oral bioavailability of about 24% (Tsai et al., Molecules, 2021).
• A 2016 study on protection against a model of Parkinson's disease, repeated in dozens of texts, was retracted by the journal in 2021. It is not a source that can be cited.
• The lion's mane mushroom is strictly protected in Poland, not partially. The raw material for supplements comes exclusively from cultivation.

What is lion's mane and where does its reputation come from?

Soplówka jeżowata is a mushroom from the family of Hericiaceae, growing on decaying hardwood, mainly beech and oak, in the temperate climate of Asia, Europe, and North America. The fruit body forms a cascading cluster of white spines, hence the names referring to a lion's mane or a hedgehog. In Japan, it is called yamabushitake, named after the wandering monks of the Shugendo sect, and in China, hou tou gu, meaning monkey head.

The neurotrophic reputation stems from one specific discovery. Hericenones were isolated from the fruit body, and erinacines from the mycelium, and both groups were attributed with the ability to stimulate the synthesis of nerve growth factor. This is why the culinary mushroom became the subject of neurobiological research, not just mycological. As you will see later, part of this story does not withstand the scrutiny of the work that is commonly cited in its support.

It is worth setting the scale right away. Soplówka is not a medicine and has not been registered for the treatment of any disease. It is an edible mushroom with a taste compared to shrimp meat, sold as a dietary supplement and as a culinary product. Everything below pertains to what has been measured in studies, not what one might expect in a specific case. The broader context of bioactive mushrooms is described in the text about medycznych grzybach i ich badaniach klinicznych.

What have studies in humans shown, and what have they not shown?

The evidence base in humans is small, and it is worth looking at it in its entirety rather than reading about it in headlines. Menon et al. conducted a systematic review in accordance with PRISMA guidelines, registered in the PROSPERO database, searching the literature from January 2000 to June 2024 (Frontiers in Nutrition, 2025). They found five randomized controlled trials, three pilot studies, fifteen laboratory works, one cohort study, and one case report.

The number 1.17 points deserves a moment's attention, as it is the most honest summary of the entire field. The MMSE scale has thirty points, and differences considered significant for the patient are usually counted in several points. An improvement of just over one point is real and measurable, but small, and comes from two studies, not twenty. This is not a basis for promises of memory restoration.

Do hericenones and erinacines really stimulate NGF?

Here lies the most commonly repeated mistake in texts about soplówka, including an earlier version of this article. The statement about hericenones stimulating the synthesis of nerve growth factor contradicts the work that is most often cited in support of it. Mori et al. examined in 2008 the effects of ethanolic extracts from four edible mushrooms on NGF gene expression in human astrocyte cells 1321N1 (Biological and Pharmaceutical Bulletin, 2008).

The extract from soplówka was the only one of the four that stimulated NGF expression, and that was dependent on concentration. The secretion of the NGF protein itself also increased, and the medium above those cells stimulated neurite growth in PC12 cells. Mice fed for seven days with a diet containing five percent dried mushroom had higher NGF expression in the hippocampus. The effect was mediated through the JNK kinase pathway, as it was abolished by a specific inhibitor of this kinase.

And now a statement that changes the entire narrative: hericenones C, D, and E, studied separately, did not stimulate the expression of the NGF gene. The authors concluded that lion's mane contains compounds that stimulate NGF synthesis, but these compounds are not hericenones. In other words, the active substance is present in the extract, but it is still unknown which one it is. Repeating that hericenones stimulate NGF is attributing a claim to the work that this work directly refutes.

The situation with erinacines is different. Spangenberg et al. systematically reviewed the studies on this group of cyathane diterpenes and described dose-dependent effects in cell and rodent models, including motor, cognitive, and depressive behaviors (Frontiers in Pharmacology, 2025). Erinacines A and C were the only ones that led to the accumulation of the transcription factor Nrf2, the main regulator of the antioxidant response. These are still animal models, not humans.

Which compounds from lion's mane reach the brain?

The question of penetration into the brain is more important in this field than activity in a petri dish, because a compound that does not reach the central nervous system will not explain the cognitive effect. The answer exists for one molecule and comes from a study on rats.

Tsai et al. administered erinacine A to rats both orally and intravenously and tracked its fate in the body (Molecules, 2021). The absolute oral bioavailability was 24.39%. Erinacine A appeared in the brain one hour after oral administration and reached its maximum there after eight hours. The ratio of the unbound fraction in the brain to the unbound fraction in the blood was close to one, which the authors interpreted as evidence of passive diffusion rather than active transport. The main route of excretion turned out to be feces.

The practical conclusion from this is twofold. First, penetration into the brain is documented for erinacine A, meaning for the compound from the mycelium, not from the fruiting body. Second, this was a study on rats, so transferring the twenty-four percent figure to humans is an overinterpretation. This is important when choosing a product: the argument about the blood-brain barrier concerns the mycelium, while most descriptions attribute it to the entire mushroom without distinction.

What is known about lion's mane in anxiety and depression?

The only clinical study in this area comes from 2010 and is small. Nagano et al. divided thirty women into a group receiving cookies with lion's mane and a group receiving cookies without it, for four weeks (Biomedical Research, 2010). After this period, the results on the CES-D depression scale and the unspecified complaints scale were significantly lower in the group with the mushroom than before the start. In two specific items of the second scale, the difference compared to placebo was also significant.

The authors added a sentence to this that disappears in popular discussions. They noted that the result suggests a mechanism different from stimulating NGF synthesis. Thus, attributing the anxiolytic effect to the nerve growth factor is added against the conclusion of the work itself.

The mechanism that currently has the best experimental support was described by Chong et al. in a model of mice subjected to chronic immobilization stress (Chinese Medicine, 2021). Four weeks of administering the extract alleviated depressive behaviors, increased BDNF expression and TrkB receptor levels, and increased the number of newly formed cells in the dentate gyrus of the hippocampus. Crucially, administering a neurogenesis blocker completely abolished the antidepressant effect. This is a strong experimental setup, but conducted on mice.

Does lion's mane protect against Alzheimer’s and Parkinson’s?

The answer is: it is unknown, and in the section concerning Parkinson's disease, it is necessary to additionally retract what has been repeated for years. There is no large study involving patients with diagnosed Alzheimer's disease. The Mori study from 2009 included individuals with mild cognitive impairment, which is a condition that can be a precursor to dementia but is not dementia itself, and the improvement disappeared after discontinuation.

Parkinson's disease is associated with a separate problem that requires clear articulation. The argument about protecting neurons from a neurotoxin used in the animal model of this disease was based in dozens of articles, including an earlier version of this text, on a study from 2016. The journal retracted this study in 2021. Retraction means that the result cannot be used as evidence, regardless of how credible it sounded and how long it circulated. We removed it from the article and do not replace it with another, as there is no equivalent study in humans.

What remains is more cautious but true. The review by Menon et al. notes neuroprotective effects and improvements in cognitive function, but mainly relies on cell and animal models. The review by Spangenberg et al. shows the activation of antioxidant pathways by erinacines, also in animal models. The practical conclusion is cognitive prevention understood as support, not therapy, and absolute neurological consultation in the case of diagnosed neurodegenerative disease.

Which of the nine declared benefits are supported by data?

The title of this entry promises nine proven actions. After reviewing the sources, the promise turns out to be too bold, so below you will find an honest account: what has human study support, what has only animal or cell model support, and what has nothing beyond repetition.

The conclusion from this table is simple and does not invalidate the sense of supplementation. Two areas have data from humans, several others have consistent animal data, and two have nothing. The mushroom remains an interesting research candidate with a good tolerance profile, but it is not what the packaging description makes it out to be. You can find a comparison of this list with another of our studies in the text about what research has shown about lion's mane in humans, and what it has not. what studies have shown about lion's mane in humans, and what they have not..

What has been shown outside the central nervous system?

Three positions from the above table deserve elaboration, as they appear stronger in commercial descriptions than they do in the sources. The first is the regeneration of peripheral nerves. Wong et al. administered an aqueous extract from fresh fruiting bodies orally to rats after crushing the sciatic nerve and assessed the return of function by analyzing gait patterns (Evidence-Based Complementary and Alternative Medicine, 2011). Limb function returned earlier than in the control group, and histological examination showed better axon regeneration and reinnervation of motor end plates. The result is consistent, but it pertains to rats and experimentally induced damage, not neuropathy in humans.

The second is the intestines, and here the data is more interesting than is usually written. A systematic review notes that the administration of lion's mane increased the diversity of gut microbiota and the abundance of bacteria producing short-chain fatty acids, which nourish the intestinal epithelium and suppress inflammation. This direction is also significant for cognitive aspects, as the gut-brain axis is one of the likely pathways through which the mushroom could affect mood. However, this does not change the fundamental limitation: the observations mainly come from animal models, not from studies in humans.

The third position is the cancer thread, which lives a life of its own on the internet. A systematic review notes that the compound erinacine A isolated from the mycelium inhibited the invasiveness of two lines of gastric cancer cells and activated caspase pathways, i.e., programmed cell death. This is an observation from cell culture. There is no study in humans that would check the effect of lion's mane on the course of cancer, and no preparation from this mushroom is an anti-cancer therapy or a supplement agreed upon with oncology.

What does the safety profile and interactions look like?

Tolerance is good, and this is consistent with common belief. In the Mori study from 2009, laboratory tests did not show adverse effects after sixteen weeks of intake. A systematic review from 2025 lists possible gastrointestinal discomfort, headaches, and allergic reactions, noting that adverse effects are sometimes simply unreported in studies on this mushroom.

This caveat about unreported events is more significant than it appears. The lack of reports is not the same as the absence of events, and with a small number of studies and short observation periods, it is impossible to describe long-term safety. People with mushroom allergies should avoid lion's mane, as allergic reactions are the only well-documented risk.

Regarding interactions with medications, it must be said plainly that data is lacking. Claims circulating on the internet about effects on blood coagulation or the lack of inhibition of specific cytochrome P450 isoenzymes have no support in studies on this species and have been removed from this text. If you are taking anticoagulants, glucose-lowering medications, or immunosuppressants, make the decision about supplementation with your doctor or pharmacist. The same caution applies to pregnancy, breastfeeding, children, and autoimmune diseases.

Separately about dosages. In this article, you will not find a recommended number of milligrams, and this is a conscious decision. We provide numbers solely as descriptions of specific studies, as supplementation taken during illness or alongside pharmacotherapy requires individual assessment that no text on the internet can replace.

Extract, powder, or fresh mushroom, how do they differ?

The difference comes down to what is actually in the product, not what sounds better on the label. The distinction between fruiting body and mycelium is substantively important, as hericenones come from the fruiting body, while erinacines come from the mycelium, and it is erinacine A that has been shown to penetrate the brain.

An extract marked by a ratio, for example, eight to one, is created by concentrating the raw material, thus providing a higher concentration of compounds in a smaller portion and longer shelf life. Double extraction, both aqueous and alcoholic, extracts both polysaccharides and terpenoids, meaning both groups of compounds that interest researchers in this mushroom. Powdered fruiting body is simply a dried and ground mushroom: a full natural profile, but lower concentration and a larger required portion.

Fresh fruiting body is primarily a culinary product. It tastes similar to shrimp meat, withstands frying in butter well, and is suitable for soups and pasta dishes. However, the content of active compounds in a serving is incomparably lower than in a preparation, so treat it as a dietary element, not as a form of supplementation. It is also worth remembering that studies in humans were conducted on dried fruiting bodies and on preparations from the fruiting body, not on dishes.

How to recognize a good Lion's Mane product?

The biggest trap in this market hides on the label under the English term myceliated grain, meaning grain overgrown with mycelium. Such raw material is mostly grain substrate with a small proportion of the mycelium itself, sold as if it were the mushroom. The label should clearly state whether it contains the fruiting body, mycelium, or both, and should not list grain fillers.

The second thing is standardization. A reputable producer provides the content of polysaccharides, preferably specifying beta-glucans, as the mere declaration of polysaccharides can be inflated by sugars from the substrate. The lack of any standardization on the packaging is a warning sign, as are declarations expressed in slogans instead of numbers.

The third thing is documentation. A certificate of analysis from an independent laboratory should cover heavy metals, pesticide residues, and mycotoxins, as mushrooms accumulate elements from the substrate well. A reliable producer provides such a document for the batch, not a vague scan from years ago. The same quality assessment principles apply to other bioactive mushrooms, which we discuss in the context of the text about the properties of shiitake mushroom..

What does Polish law say about lion's mane?

Here we correct a mistake that is repeated in Polish descriptions of this species, including an earlier version of this article. Lion's mane is not partially protected in Poland. It is under strict protection.

The basis is the regulation of the Minister of the Environment from October 9, 2014, on the species protection of fungi (Dz.U. 2014 poz. 1408), an act still in force. The species is listed in the first annex, covering fungi under strict protection, in the forty-ninth position, with a designation indicating the need for active protection. Under partial protection, meaning in the second annex, there are two other species from the same genus: beech lion's mane and fir lion's mane.

The practical consequence is clear. Fruiting bodies of lion's mane cannot be collected in Polish forests, and a find is a natural curiosity, not a raw material. All raw material present on the market comes from controlled cultivation conducted on lignocellulosic substrates, and this is the only legal way to obtain it.

A separate layer concerns the product status. Lion's mane is sold in Poland as a dietary supplement, and the producer cannot attribute health claims to it that have not been approved under European Union food law. For this species, no health claims have been approved, so the packaging cannot promise either treatment or memory improvement. Cautious language on labels is not a marketing ploy but a boundary set by regulations, and an overly bold slogan is a signal that the producer does not respect this boundary.

Is it worth combining lion's mane with CBD?

The combination is often suggested because both substances are described as acting on the nervous system through different pathways. However, it must be stated clearly: there is no study that has tested such a combination in humans. Everything that can be written on this topic is a compilation of two separate data sets, not a description of studied synergy.

On the CBD side, the state of knowledge changed in 2026. The EFSA panel published an update on the safety of cannabidiol as a novel food, establishing a provisional safe dose of 0.0275 mg per kilogram of body weight per day, which for a person weighing 70 kg amounts to about 2 mg (EFSA, 2026). This value applies to supplements with a purity of cannabidiol of at least 98%, without nanoparticles.

From the same document comes a caveat that must be stated directly with every text touching on dosing: the safety of cannabidiol cannot be established in individuals under 25 years of age, in pregnant and breastfeeding women, and in people taking medications. Since the reader of a text about cognitive support may indeed be someone taking medications, combining both preparations on one's own is a bad idea. We detail the mechanisms of interaction of adaptogens in the text about the synergy of CBD and adaptogens.

For whom does lion's mane make sense, and for whom does it not?

The most honest answer is: for a healthy person, curious and willing to give the preparation several weeks and treat the effect as possible, not certain. Studies in humans primarily involved older individuals with mild cognitive impairments, and the improvement was small and reversed after discontinuation. If someone expects a noticeable change after a week, they will be disappointed for reasons inherent in the design of these studies, not in the quality of the product.

There are several situations in which it should be advised against, and these are not precautionary formulas. An allergy to mushrooms excludes supplementation. Pregnancy, breastfeeding, and childhood indicate a lack of data, and a lack of data is not evidence of safety. In the case of autoimmune disease, anticoagulant treatment, and diabetes, the decision is made with a doctor, precisely because it is unknown how mushrooms interact in these situations.

Finally, a word about expectations. Lion's mane does not replace sleep, exercise, or treatment. It is not equivalent to medications used in dementia or depression and has not been studied for these purposes in a way that would allow for such a comparison. It is a supplement with good tolerance, with one well-documented and small cognitive effect and several promising directions studied in animals. Thus, it is worth treating it as such.

Frequently Asked Questions

What is Lion's Mane and what does it contain?

Lion's mane, or Hericium erinaceus, is an edible mushroom containing two characteristic groups of compounds: hericenones in the fruiting body and erinacines in the mycelium. Erinacines are cyathane diterpenes, and erinacine A has been shown to penetrate the blood-brain barrier in rats through passive diffusion. The Polish names for this species are lion's mane and Hericium erinaceus.

Does lion's mane improve memory and concentration?

In human studies, the improvement is measurable but small. A systematic review from 2025 reports a total improvement in the MMSE scale of 1.17 points out of thirty possible. In the study by Saitsu et al., of the three cognitive tests used, only the MMSE showed a difference, while the other two did not.

Do hericenones stimulate nerve growth factor?

No, contrary to what most descriptions repeat. In the study by Mori et al. from 2008, hericenones C, D, and E did not stimulate the expression of the NGF gene in human astrocyte cells. The extract from the whole mushroom stimulated it, and the authors stated directly that the compounds responsible for this effect are not hericenones.

Does lion's mane help with anxiety and low mood?

There is one small study in humans: thirty women taking cookies with added mushroom for four weeks had lower scores on the CES-D depression scale. The authors noted that the mechanism is likely different from NGF stimulation. Mouse data indicate neurogenesis in the hippocampus.

Does lion's mane help with Parkinson's disease?

There is no basis for such a claim. A 2016 study on neuron protection in an animal model of this disease, repeated in dozens of articles, was retracted by the journal in 2021. Retraction means that the result cannot be used as evidence, and there is no equivalent study in humans.

Is lion's mane safe and what are its side effects?

Tolerance is good. A systematic review from 2025 lists gastrointestinal complaints, headaches, and allergic reactions, noting that adverse effects may be underreported. Individuals with mushroom allergies should avoid supplementation. There is a lack of data on long-term safety and drug interactions.

Fruit body or mycelium, which to choose?

It depends on which compound you are referring to. Hericenones come from the fruit body, while erinacines come from the mycelium, and it has been shown that erinacine A penetrates the brain in a study on rats. Products combining both raw materials cover a broader spectrum. Avoid preparations based on grain overgrown with mycelium, as they mainly consist of cereal substrate.

Can the lion's mane mushroom be collected in Polish forests?

No. The species is strictly protected in Poland based on the regulation of the Minister of the Environment from October 9, 2014, regarding the protection of mushroom species, indicating the need for active protection. All raw material available on the market comes from controlled cultivation, and that is the only legal way to obtain it.

Preparaty z grzybami bioaktywnymi znajdziesz w dziale adaptogens.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-05-11 · Aktualizacja: 2026-08-10